Impel NeuroPharma, a pharmaceutical company focused on transformative therapies for diseases with high unmet medical needs, has appointed Leonard S. Paolillo as chief commercial officer and Gerald F. Penn as vice president, market access and trade. These key management additions build out the commercial infrastructure in preparation for the potential launch of TRUDHESA for the acute treatment of migraine headaches, subject to U.S. FDA approval.   Mr. Paolillo joins the company from Kyowa Kirin...